Ambu acquired Invendo Medical along with its single-use endoscope business for €225 million ($265 million.)
Here's what you should know:
1. Ambu agreed to make contingent payments up to €110 million ($129 million) as part of the deal. The contingencies were not disclosed.
2. Invendo Medical develops sterile, single-use, high-definition endoscopy products for gastroenterologists. Invendo developed the world's first single-use GI platform.
3. In 2018, Invendo expects its HD colonoscope to earn both FDA approval and a CE mark.
4. Invendo has been active in the single-use pulmonary endoscopy field to the tune of 5 million annual procedures.
Ambu CEO Lars Marcher said in a release, "This acquisition is a massive upgrade of our business potential. We introduced single-use endoscopy for airway procedures with the Ambu aScope, and now, we will get ready to introduce single-use for the gastrointestinal procedures. This is an important acquisition that puts Ambu in an ideal position to further disrupt the reusable market within endoscopy."